Nomura Holdings
ABMD

Nomura Holdings’s Abiomed Inc ABMD Stock Holding History

Nomura Holdings’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,207
Closed -$409K – 2269
2022
Q1 		$409K Buy
1,207
+252
+26% +$77.6K ﹤0.01% 1359
2021
Q4 		$344K Sell
955
-517
-35% -$175K ﹤0.01% 1640
2021
Q3 		$476K Buy
1,472
+225
+18% +$76.2K ﹤0.01% 1439
2021
Q2 		$389K Buy
+1,247
New +$383K ﹤0.01% 1483
2021
Q1 		– Sell
-1,634
Closed -$530K – 2375
2020
Q4 		$530K Buy
1,634
+516
+46% +$143K ﹤0.01% 1221
2020
Q3 		$310K Sell
1,118
-2,079
-65% -$599K ﹤0.01% 1112
2020
Q2 		$772K Buy
+3,197
New +$642K ﹤0.01% 772
2020
Q1 		– Sell
-5,326
Closed -$909K – 1293
2019
Q4 		$909K Sell
5,326
-1,312
-20% -$243K ﹤0.01% 818
2019
Q3 		$1.13M Sell
6,638
-1,071
-14% -$232K ﹤0.01% 799
2019
Q2 		$2.04M Buy
7,709
+3,765
+95% +$999K 0.01% 683
2019
Q1 		$1.1M Sell
3,944
-59,751
-94% -$19.9M ﹤0.01% 806
2018
Q4 		$20.7M Sell
63,695
-3,704
-5% -$1.29M 0.08% 196
2018
Q3 		$30M Sell
67,399
-6,136
-8% -$2.42M 0.11% 171
2018
Q2 		$30.1M Buy
73,535
+69,073
+1,548% +$25M 0.1% 166
2018
Q1 		$1.3K Buy
+4,462
New +$1.13M ﹤0.01% 989
2017
Q3 		– Sell
-6,193
Closed -$888K – 1668
2017
Q2 		$888K Buy
+6,193
New +$832K ﹤0.01% 1074
2015
Q1 		– Sell
-9,169
Closed -$337K – 2388
2014
Q4 		$337K Buy
+9,169
New +$289K ﹤0.01% 1846
2014
Q3 		– Sell
-8,871
Closed -$221K – 3136
2014
Q2 		$221K Sell
8,871
-3,170
-26% -$73.8K ﹤0.01% 2323
2014
Q1 		$316K Buy
+12,041
New +$333K ﹤0.01% 2050
2013
Q3 		– Sell
-17,559
Closed -$379K – 2672
2013
Q2 		$379K Buy
+17,559
New +$353K ﹤0.01% 1482

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nomura Holdings's ABMD Position: Q2 2022 in Review

Nomura Holdings sold out of Abiomed Inc (ABMD) in Q2 2022, closing a stake of 1,207 shares — an estimated $409K sold.

Nomura Holdings first reported a position in ABMD in Q2 2013 and held it in 20 quarters. The position peaked at $30.1M in Q2 2018. 496 funds tracked by Wall St. Rank hold ABMD as of Q2 2022.

  • Nomura Holdings reported no remaining Abiomed Inc position as of Q2 2022 after selling out during the quarter.
  • Nomura Holdings sold 1,207 Abiomed Inc shares in Q2 2022, an estimated $409K.
  • Nomura Holdings first reported a position in Abiomed Inc in Q2 2013 and held it in 20 quarters.
  • Nomura Holdings's Abiomed Inc position peaked at $30.1M in Q2 2018.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2022.

Based on Nomura Holdings's 13F filing for Q2 2022, filed 15 Aug 2022.